Tower Research Capital LLC (Trc) Adagio Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.39 Billion
  • Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,609 shares of ADGI stock, worth $35,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,609
Previous 15,211 30.25%
Holding current value
$35,115
Previous $50,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
N/A
-4,602 Reduced 30.25%
10,609 $35,000
Q2 2025

Aug 14, 2025
SELL
N/A
-992 Reduced 6.12%
15,211 $50,000
Q1 2025

May 15, 2025
SELL
N/A
-3,756 Reduced 18.82%
16,203 $53,000
Q4 2024

Feb 13, 2025
BUY
N/A
11,158 Added 126.78%
19,959 $66,000
Q3 2024

Nov 14, 2024
BUY
N/A
5,901 Added 203.48%
8,801 $29,000
Q2 2024

Aug 13, 2024
SELL
N/A
-13,421 Reduced 82.23%
2,900 $9,000
Q1 2024

May 15, 2024
BUY
N/A
10,794 Added 195.3%
16,321 $54,000
Q4 2023

Feb 13, 2024
SELL
N/A
-9,096 Reduced 62.2%
5,527 $18,000
Q3 2023

Nov 14, 2023
SELL
N/A
-1,554 Reduced 9.61%
14,623 $48,000
Q2 2023

Aug 14, 2023
BUY
N/A
2,426 Added 17.64%
16,177 $53,000
Q1 2023

May 09, 2023
SELL
N/A
-18,877 Reduced 57.86%
13,751 $16,000
Q4 2022

Feb 10, 2023
BUY
$3.08 - $4.05 $92,985 - $122,269
30,190 Added 1238.31%
32,628 $49,000
Q3 2022

Nov 10, 2022
SELL
$2.97 - $4.83 $5,313 - $8,640
-1,789 Reduced 42.32%
2,438 $7,000
Q2 2022

Aug 15, 2022
SELL
$2.54 - $4.52 $13,680 - $24,344
-5,386 Reduced 56.03%
4,227 $14,000
Q1 2022

May 12, 2022
BUY
$3.81 - $10.77 $17,026 - $48,131
4,469 Added 86.88%
9,613 $44,000
Q4 2021

Feb 14, 2022
BUY
$6.35 - $47.04 $28,200 - $208,904
4,441 Added 631.72%
5,144 $37,000
Q3 2021

Nov 15, 2021
BUY
$20.88 - $56.08 $14,678 - $39,424
703 New
703 $30,000

Others Institutions Holding ADGI

# of Institutions
82
Shares Held
153M
Call Options Held
244K
Put Options Held
167K
View Full List

About Adagio Therapeutics, Inc.

ADGI Quotes by TradingView
  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email